EUVIMEDEUVIMED entdecken
Crossref

Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test

Elisabeth Mahase

BMJ · 2024

DOI: 10.1136/bmj.q744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMJ, 2024. Verfasst von Elisabeth Mahase. Beteiligte Einrichtung: The BMJ. Hauptthemen laut MEDLINE: Advertising, Diabetes Mellitus, Type 1. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdvertisingDiabetes Mellitus, Type 1HumansAcetamidesFear

Substanzen

CDAAAcetamides

Autor:innen und Institutionen

  • The BMJ.

Zitieren

APA

Mahase, E. (2024). Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test. BMJ. https://doi.org/10.1136/bmj.q744

Vancouver

Mahase E. Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test. BMJ. 2024. doi:10.1136/bmj.q744

BibTeX
@article{Mahase2024,
  author = {Mahase, Elisabeth},
  title = {Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test},
  journal = {BMJ},
  year = {2024},
  doi = {10.1136/bmj.q744}
}
Kostenlos starten →